While research on true transdermal GLP-1 delivery systems is underway, with promising early results in animal studies, no such products are currently available to consumers
[DOI] [PMC free article] [PubMed] [Google Scholar] 203.Algotar A., Trofymenko S., Muramoto M., Howerter A., Kutob R
All GLP-1 medications start low and gradually increase every 4 weeks (weekly formulations) or weekly (daily formulations) to minimize gastrointestinal side effects
In April 2025, Novo announced an additional investment of more than $1 billion to expand its production site in Montes Claros, Minas Gerais, Brazil, with operations expected to begin in 2028
10.1523/JNEUROSCI.0529-11.2011
Start the conversation with your clinical provider about what happens to your care if the regulatory situation changes